Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Sanara MedTech (SMTI) Long-Term Deferred Tax (2017 - 2019)

Sanara MedTech's Long-Term Deferred Tax history spans 4 years, with the latest figure at $1.9 million for Q4 2019.

For Q4 2019, Long-Term Deferred Tax changed N/A year-over-year to $1.9 million; the TTM value through Dec 2019 reached $1.9 million, changed N/A, while the annual FY2019 figure was $1.9 million, N/A changed from the prior year.
Long-Term Deferred Tax reached $1.9 million in Q4 2019 per SMTI's latest filing, down from $7.3 million in the prior quarter.
In the past five years, Long-Term Deferred Tax ranged from a high of $11.8 million in Q4 2015 to a low of $1.9 million in Q4 2019.
Average Long-Term Deferred Tax over 3 years is $7.0 million, with a median of $7.3 million recorded in 2017.